Home - Cellab CDMO Cellab CDMO Cellab CDMO | Contract Development & Manufacturing Organization (CDMO) for Cell and Gene Therapy

Your Partner in Advanced Therapy Development and Manufacturing

End-to-end ATMP solutions – from early development to clinical manufacturing

Acting as an extension of your team, Cellab CDMO delivers integrated solutions for your ATMP from early development to clinical application.

About

CGT CDMO

Cellab CDMO is a specialized advanced therapy CDMO combining cell banking and GMP manufacturing under a unified quality framework.

We provide a fully integrated, end-to-end model supporting your therapy from early development to clinical application, ensuring alignment across process development, starting material sourcing, manufacturing, cryopreservation, quality, and regulatory requirements.

BROAD EXPERTISE ACROSS ADVANCED THERAPY PLATFORMS

We support a wide range of advanced therapies, including:

Mesenchymal stem cells (MSC)
Gene-modified cell therapies (CAR-T)
Hematopoietic stem and progenitor cells
Immune cell therapies (PBMCs, T cells)
Induced pluripotent stem cells (iPSCs)
& More

INTEGRATED FULL-CYCLE, ALIGNED, CLINICAL-READY

Our approach integrates scientific and process development expertise, GMP manufacturing, regulatory support, and logistics into a single streamlined workflow, reducing complexity and accelerating your path to the clinic.

Do you have a project in development?

FROM BENCH TO BEDSIDE

Cellab CDMO supports the full lifecycle of advanced therapies, ensuring seamless integration from early development to clinical manufacturing.

THERAPY STAGE NAVIGATION

Where are you in your development?

We adapt our aproach to your therapy stage, ensuring the right strategy from early development to clinical manufacturing.

EARLY DEVELOPMENT

Process design, scability and initial strategy.

PRECLINICAL

GMP transition and QC strategy

CLINICAL STAGE

GMP manufacturing and regulatory support

Other services

Starting material sourcing:

Accredited AABB cell bank, we carefully assess both your current objectives and long-term development needs to identify and secure the most suitable starting material.

Cell bank:

Accredited GMP cell bank, ensuring a fully regulated environment with continuous 24/7 monitoring to maintain quality, security, and traceability at every stage.

WHY CHOOSE CELLAB

Acting as an extension of your team

We integrate closely with our partners, supporting strategic decision-making, process optimization, and problem-solving throughout development.

Integrated end-to-end model:

From development to clinical manufacturing, we ensure alignment across all stages, reducing fragmentation and accelerating timelines.

Scientific and technical expertise

Strong specialization in preserving sensitive biological materials while maintaining viability and potency.

Quality and regulatory excellence

GMP and AABB accreditations ensure high standards of compliance, traceability, and product quality.

Cryopreservation and cell banking expertise

Strong specialization in preserving sensitive biological materials while maintaining viability and potency.

Reliable and agile logistics

Proven expertise in international transport of biological (materials)samples and ATMPs, including temperature-controlled and time-critical shipments.

EU QP Release

Reliable and efficient European batch release of ATMPs, ensuring full regulatory alignment and rapid market readiness.

SERVICES

We offer a broad range of services, tailored made and highly adaptable to the clients need. It includes bioprocess scaling design from R&D to GMP, ATMP manufacturing, GMP batch release, GMP storage area, among others.

R&D and Process Development

Design and optimization of scalable, GMP-compliant processes, including mechanism of action-driven potency assays.

● Seamless transition from early development to GMP-compliant manufacturing.
● Process optimization to improve efficiency and reduce costs while maintaining full compliance with GMP standards.
● Collaborative, hands-on approach integrated with your team.
● Advanced therapy expertise with MoA-driven potency assay design.
● Process Scale-up

GMP and GMP-Like Manufacturing

Flexible and tailored manufacturing of advanced therapies, including cell processing, expansion, gene-modified products.

● Clinical-grade manufacturing of cell and gene therapies.
● Scalable processes adapted to autologous and allogeneic approaches.
● Cell selection, processing, expansion, and conditioning. Manufacturing of gene-modified products (e.g., CAR-T).
● Fill & finish and closed-system processing.
● Sourcing and relabeling of commercially available products for use as clinical trial placebo and ancillaries.

Quality Control

Comprehensive characterization and release testing aligned with regulatory requirements.

● Identity, purity, and viability testing.
● Sterility, endotoxin and mycoplasma detection.
● Potency assays aligned with mechanism of action.
● In-process and final product testing.
● Stability studies and product characterization.
● Batch release testing under GMP and Eur. Ph standards.

Regulatory Support

Development of regulatory documentation, including IMPD quality sections and GMP compliance strategies.

● IMPD drafting with focus on the Quality section (CMC).
● Preparation of regulatory documentation aligned with EU requirements.
● Definition of GMP compliance strategies.
● Support for clinical trial submissions.
● Alignment between development, manufacturing, and regulatory expectations.

Logistics and EU QP release

Global logistics solutions ensuring safe, compliant, and traceable transport of biological materials.

● Global transport of biological materials under temperature controlled conditions.
● Temperature-controlled shipping (LN₂, −80°C, −20°C, 2–8°C, 15-25ºC)
● Import/export coordination and customs support
● Chain of custody and full traceability.
● Validated transport routes and qualified logistics partners.
● Time-critical and patient-specific shipment management.
● EU QP Release through our validated partners.

GMP Cell Banking & Cryopreservation

Design and execution of cryopreservation strategies, storage, and recovery optimization.

●Master and Working Cell Bank (MCB/WCB) generation under GMP conditions.
●Starting material selection and qualification.
●Cryopreservation protocol design and optimization.
●Controlled-rate freezing and validated storage. (LN₂ systems).
●Full traceability and documentation aligned with regulatory requirements.
●Long-term storage and stability management

GET EXPERT FEEDBACK ON YOUR THERAPY

Share a few details and our team will get back to you with tailored insights.

FACILITIES

STATE-OF-THE-ART INFRASTRUCTURE FOR ATMP MANUFACTURING

Our purpose-built facility is designed to support the complete lifecycle of Advanced Therapy Medicinal Products (ATMPs), from early development to GMP manufacturing.

With over 1,000 m² of infrastructure, Cellab combines advanced technology with smart facility design to ensure efficiency, flexibility, and full regulatory compliance.

GMP Cleanrooms

4 Grade B and 1 Grade C cleanrooms, fully independent to ensure strict segregation and eliminate any risk of cross-contamination

Quality control Laboratories

2 fully equipped QC labs supporting in-process and release testing

Cryogenic Storage

Dedicated area (50 m²) for the secure preservation of cell banks and critical biological materials

R&D Facilities

Spaces designed to accelerate process development and seamless GMP translation

All areas operate under a robust Quality Management System (QMS), with controlled environments, validated equipment, and full traceability.

Our modular and independent cleanroom design enables parallel manufacturing activities, ensuring flexibility while maintaining the highest standards of quality and safety.

Built to scale your therapy from bench to bedside.

WHO WE PARTNER WITH & PROVEN EXPERTISE

Trusted partner for advanced therapy development

After defining your development and manufacturing strategy, choosing the right partner is critical.

We collaborate with international biotech and pharmaceutical companies, hospitals, and research institutions to bring advanced therapies to the clinic.

Who we work with

Trust & credibility

Built on quality, experience, and regulatory compliance
GMP-compliant manufacturing
AABB-accredited cell banking
More than10 years of experience in cell processing and cryopreservation
Experience supporting clinical-stage products

Experience

Proven experience across advanced therapy programs
Support from early development to clinical manufacturing
Experience with autologous and allogeneic therapies
Strong expertise in cryopreservation and logistics
Integrated approach across development, GMP, QC, and regulatory

TEAM

Our team of experienced and enthusiastic professionals bring a deep understanding of GMP requirements, regulatory standards, and industry best practices to every project we undertake. Discover more about this dynamic group who are poised to facilitate the journey of your therapy.

Alexandre Marfany Pluchart

Chief Executive Officer

Alex joined Cellab as CEO in 2020 and leads our team with strong focus on strategic growth and innovation. He holds a BSc in Business Administration and brings over 5 years of experience in managing different companies to his leadership role.

Alba Casamayor Genescà, PhD

Chief Operating Officer & Head of QC

Alba has been an integral part of Cellab since 2013, serving as COO and Head of QC. She oversees our operations with a focus on maintaining high-quality standards. She has over 15 years of experience in both ATMP research & manufacturing under GMP along with managing QC, cells and tissue banks accordance with AABB standards and holds a BSc in Biotechnology, MSc in Advanced Biotechnology and a PhD in Biotechnology.

Ariadna Sanglas
Baulenas

Chief of quality control

Ariadna joined Cellab in 2025 as Head of Quality Control, overseeing quality management, process validation, and staff training in ATMP and cellular product manufacturing. She holds a PhD in Biotechnology from the University of Barcelona and has experience in biotechnology and diagnostics, including ISO 13485 implementation and BSL-2 lab management.

Raquel Calderon Almendro, PhD

Chief of Quality Officer & QP

Raquel joined Cellab in 2021 and as Chief Quality and Compliance Officer, she plays a pivotal role in ensuring our products meet regulatory standards and quality requirements. Raquel has over 10 years of experience in the pharmaceutical industry, including positions as QA and QP under GMP and holds a BSc in Pharmacy, an MSc in Pharmaceutical Industry and a PhD in Biomedical Chemistry

Clara Boces Pascual, PhD

Chief R&D integration and GMP Development

Clara joined Cellab in 2020 as Chief of R&D Integration and GMP Development leading our efforts in integrating R&D strategies with GMP standards. She holds a BSc in Biology, MSc in Biomedicine and a PhD in Biomedicine and has over 10 years of dedicated experience in R&D within Biomedicine focusing on Process Development of GMP Biological Therapies.

Claudia Pujol Bonaparte

Chief Manufacturing Officer & Head of Production

Claudia joined Cellab in 2016 as Chief Manufacturing Officer and Head of Production overseeing all aspects of manufacturing operations with a focus on efficiency and quality. She holds a BSc in Chemistry and an MSc in Pharmaceutical Industry and has more than 10 years of experience in managing biological bank samples under AABB standards, as well as processing and manufacturing ATMPs under GMP regulations.

Business Developer

Paul joined Cellab in 2024 as Business Developer and is dedicated to expanding our business opportunities and driving growth. He holds a BSc in Chemistry & Biochemistry and an MSc in Biochemistry with Major in Biomedicine. With 5 years of experience in both research and business development, Paul bridges the gap between science and business to advance novel ATMPs towards commercialization.